Antiepileptic drug in pregnancy

Uploaded on

안현숙 전임의(관동대 제일병원 산부인과)

안현숙 전임의(관동대 제일병원 산부인과)

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On Slideshare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Antiepileptic Medicationsduring Pregnancy주산기 전임의 안현숙
  • 2. >Incidence of Seizure>The most frequent major neurologic complication encountered inpregnancy>Approximately 1% of the general population. (Brodie and Dichter, 1996)>Pathophysiology>Paroxysmal dosorder of the CNS>Abnormal neuronal discharge with or without loss of consciousness>Two broad categories of epileptic syndrome:-Partial seizure-Generalized seizureIntroduction
  • 3. <Partial seizure>-15% of all seizure-Trauma, abscess, tumor, or perinatal factors1.Simple motor seizures-Can affect sensory function of produce autonomic dysfunction orpsychological changes-Consciousness is usually not lost, and recovery is rapid2.Complex partial seizures-Called temporal lobe or psychomotor seizures-Involve clouding of consciousness
  • 4. <Generalized Seizures>-85% of seizure-Involve both brain hemispheres spontaneously-Preceded by an aura before an abrupt loss of consciousness-Related with strong hereditary component1.Grand mal seizure-Status epilepticus-With loss of consciousness-Tonic contraction of the muscles-Rigid posturing-Clonic contraction of all extrimities
  • 5. 2.Petit mal seizures-Absence seizures-Involve a brief loss of consciousness without muscle activity-Immediate recovery of consciousness and orientation>Causes of Seizures:-Trauma-Alcohol- and other drug-induced withdrawals-Brain tumors-Biochemical abnormalities-Arteriovenous malformation
  • 6. >Prevalence of epilepsy in adults in 2005: approx. 1.65%(The Centers for Disease Control and Prevention, Kobau and colleagues, 2008)>Incidence of pregnant women w/ epilepsy: 0.5% of all pregnancy>Seizure disorders complicate 1 in 200 pregnancies(Brodie and Dichter, 1996)>What are major pregnancy-related threats to womenwith epilepsy?- Increased seziures rates- Risks for fetal malformationEpilepsy during Pregnancy
  • 7. >Increased seziures rates-subtherapeutic anticonvulsant levels and lower seizures threshold-Can be caused by nausea and vomiting-Decreased gastrointestinal motilily and use ofantacids that diminish drug absorption-Pregnancy hypervolemia offset by protein binding-Induction of hepatic, plasma, and placental enzymesthat increase drug metabolism-Increased glomerula filtration-Discontinue medication-Pregnancy-related sleep deprivation, hyperventilation and painduring labor
  • 8. >Risks for fetal malformation-Untreated epilepsy is not associate with increased malformations.-But the fetus of an epileptic mother who takes anticonvulsantmedications has an indisputably increased risk of congenitalmalformation.(Thomas and co-workers, 2008; Viinikainen and colleagues, 2006)-Teratogenic effects of antiepileptic drugs1)Pregnancy loss2)Intrauterine growth retardation3)Congenital malformation4)Impaired postnatal development5)Behavioural problems6)Fetal anticonvulsant syndromes
  • 9. >Carbamazepine-Relatively slow absorption-70~80% protein binding to albumin-Main route of elimination : Hepatic metabolism-Drug levels and bioavailability tend to be lower in pregnancy-Carbamazepine-10,11-epoxide: increase during pregnancyimpaired conversion of carbamazepineincreased carbamazepine metabolismPregnancy-induced pharmacokineticchanges of antiepileptic drugs
  • 10. >Phenytoin-Highly bind to protein(90~93%)-Main route of elimination : Hepatic metabolism-8-hydoxylation: substantial increased duringpregnancy increased clearance rate andconsequently decreased serum concentration fall in total serum phenytoin concentration cause lack of seizure control>Phenobarbital-Sedation and impaired cognitive function-High oral bioavailability(90%), protein-bound(50%)-Induced hepatic microsomal oxidative enzymes-Main route of elimination : Hepatic metabolism-Long elimination half life
  • 11. >Valproic acid-Rapidly absorption-Highly protein-bound to plasma albumin(88~92%)-Pharmacokinetics limitation by:1)large fluctuation in the concentration–time profile2)wide therapeutic index3)concentration-dependent protein binding-Dose adjustments during pregnancy
  • 12. >New antiepileptic drug:Topiramate, Felbamate, Oxcarbazepine, Gabapentin,Vigabatrin, Lamotrigine-no antifolate effects-no arene oxide metabolites-no effects on the cytochrome P-450enzyme system-Eliminated from the body throughrenal clearanceThere is little informationregarding their pharmacokineticsand safety during pregnancy.
  • 13. 1. Some anticonvulsant medication form intermediate oxidemetabolites that are known to be embryotoxic.-Free active oxide radicalsbind to proteins and nucleic acidsinterfere with DNA and RNA synthesis-Critical amounts of free radicals mayincrease the risk of perinatal death, intrauterinegrowth retardation, and malformationsMechanisms and clinicalimplications of teratogenicity
  • 14. 2. Another mechanism that has been implicated in AED- mediatedteratogenicity is folate deficiency.-Up to a 90% reduction of serum folate levels(Ogawa Y, et al 1991)3. Genetic predisposition:Decreased epoxide hydrolase activity
  • 15. Teratogenic effects of antiepileptic drugsDepartment of Clinical Neuroscience, KarolinskaInstitutet, Stockholm, SwedenRates of major congenital malformations in six different registriesLancet Neurol 2012; 11: 803–13
  • 16. Teratogenic effects of antiepileptic drugsDepartment of Clinical Neuroscience, KarolinskaInstitutet,Stockholm, SwedenLancet Neurol 2012; 11: 803–13
  • 17. >Major goal is seizure prevention-Treatment for nausea and vomiting-Prevention seizure-provoking stimuli-Medication compliance-Anticonvulsants should be maintained at the lowest dosageassociated with seizure control.Management in Pregnancy
  • 18. -Routinely monitor serum drug levels during pregnancy-Specialized sonographic exam for identifyinganomalies at midpregnancy>Monotherapy : low birth defect-Increases the major malformation rate 2~ 3 fold(therapy with phenytoin, phenobarbital,carbamazepine)(Perucca, 2005; Thomas and associates, 2008)-Valproate: increase the risk to as high as 4~8 fold(Eadie, 2008; Wyszynski and colleagues, 2005)
  • 19. >Effect of antiepileptic drugs on vitamin KVitamin K deficiency-Neonatal hemorrhage-increased degradation of vitamin K(enzyme–inducing AEDs such as carbamazepine,phenytoin, phenobarbital, primidone)The consensus guidelines:Antenatal maternal vitamin K supplementation at20mg orally throught the last 4 weeks of gestationaland 1mg of vitamin K parenterally to the neonateimmediately after deivery.
  • 20. >Preeclampsia>Postpartum hemorrhage>Postpartum depression>Increased cesarean section rate>Nonproteinuric hypertension>Increased incidence of labor induction>Developing a seizure disorder of epileptic mother’s childrenPregnancy compication
  • 21. >Adverse outcome of an epileptic women’s pregnancy depends on:-AED-induced teratogenecity-Patient’s genetic disposition-Serverity of patient’s convulsive disorder>Potential risk of increased seizure activity during pregnancy so as tomake sure that they do not avoid taking their medication.>Should optimally begin at least 3 month before conception to allowfor adequate supplementation of folic acid>Need to adequate patient education increased incidence of majormalformations possible adverse effects of AEDs to the fetal CNSsystemPreconceptional counseling
  • 22. >Genetic counseling>Quit smoking, maintain good nutrition, get enough sleep>Gradual Drug discontinuation(over at least 3 months)-Seizure-free for 2 or more years>Cannot be avoided anticonvulsant medication:-Should be achieved by the lowest effective dose of the single AED-Folate supplementation at 5mg/day should start 3 months beforeconception and continue until the end of the first trimester
  • 23. >Proper seizure control is the primary goal in treating women withepilepsy.>Should understand the risks associated with uncontrolled seizures>Should be used at the lowest effective dose: first-line drug>Judicious preconceptional, antenatal and postpartum management forfavorable maternal and neonatal outcomeConclusion
  • 24. Thank you for yourattention